Vaccination is one approach to covid, triggering acquired immunity. But what else can be employed a) to support innate immunity and b) to supress viral replication? In this month’s podcast I’ll be updating you on three strong candidates – vitamin C, vitamin D and the anti-parasite drug Ivermectin – by talking to vitamin D expert Dr David Grimes and Ivermectin expert Dr Tess Lawrie as well as updating you on a review of 12 vitamin C for covid trials.
David Grimes qualified in medicine at Manchester University in 1966. He was appointed Consultant in General Medicine and Gastroenterology in Blackburn, Lancashire, in 1977 and he finally retired at the end of 2014. He was concerned about the geographic, social and ethnic variations in health affecting his patients and the local population, and this led to a long research interest that identified the immense importance of vitamin D in our health.
Dr Tess Lawrie is founder of the British Ivermectin Recommendation Development Group (bird-group.org), is the Director of the Evidence-Based Medicine Consultancy Ltd, and founded the community interest company EbMCsquared this year to address the public need for transparent and objective research related to covid-19 therapeutics. She is author of over 80 published research papers and is committed to improve the quality of healthcare globally through rigorous research as a founder member of the World Council for Health.
See my website for my latest Covid News and the 12 Trials review - click on the tab Blogs and Reports.